1914

İneklerde Retensiyo Sekundinarum Proflaksisi Üzerine Butafosfan ve Vitamin B12’nin Birlikte Uygulanmasının Etkisi

Bu çalışmanın amacı ineklerde Retensiyo sekundinarum'un proflaksisi üzerine Butafosfan ve Vitamin B12kombinasyonunun etkisini belirlemekti. Klinik olarak sağlıklı 114 gebe Holstein ırkı inek, tahmin edilen buzağılamadan yedi gün önce rastgele olarak iki deney grubuna ayrıldı. Deneme Grubuna (DG, n=57) Butafosfan (100mg/ml) ve Vitamin B12(0,05 mg/ml) kombinasyonunu tahmin edilen buzağılamadan bir hafta önce 3 ardaşık gün günde bir kez ve buzağılama gününde derialtı 5 ml/100 kg vücut ağırlığı dozunda uygulandı. Kontrol Grubuna (KG), DG'ninkine benzer şekilde serum fizyolojik solüsyonu enjekte edildi. Beta hidroksi bütirik asit (BHBA) konsantrasyonunu belirlemek için tahmin edilen buzağılamadan yedi gün önce ve postpartum 0. ile 3. günlerde ineklerden kan alındı. Postpartum 0 ve 3. günde DG'deki ineklerin serum BHBA konsantrasyonları KG'deki ineklerden daha düşüktü (P

The Effects of Butaphosphan and Vitamin B12 Combination on the Prophlaxis of Retained Placenta in Cows

The objectives of this study were to determine the effects of Butaphosphan and Vitamin B12 combination on the prophlaxy of retained placenta in cows. 114 clinically healthy pregnant Holstein cows were assigned randomly into two experiment groups at seven day before expected calving. In Trial Group (Group T; n=57), butaphosphan (100mg/ml) and Vitamin B12 (0.05 mg/ml) compound was applied at a dose of 5 ml/100 kg of body weight s.c., once a day for 3 consecutive days one week before expected calving date, and at calving day. Control Group (Group C; n = 57) was received injections of saline solution in the same way that the Group T. Blood was collected from cows at 7 day before their expected calving date and 0 day and 3 days postpartum to determine concentrations of beta-hydroxybutyric acid (BHBA). The cows in Group T had lower (P

PDF

___

Akar Y, Kızıl Ö, Saat N, Yüksel M, 2012: The effect of oxytocin and cloprostenol application via umbilical artery immediately after dystocia on time and rate of fetal membrane removal in cows. Turk J Vet Anim Sci, 36(3), 275-281.
Akar Y, Yıldız H, 2005: Concentrations of some minerals in cows with retained placenta and abortion. Turk J Vet Anim Sci, 29, 1157-1162.
Alšić K, Domaćinović M, Pavičić Ž, Bukvić Ž, Baban M, Antunović B, 2008: The relationship between diet and retained placenta in cows. Acta Agric Slov, supl. 2, 155–162.
Arslan C, Tufan T, 2010: Geçiş dönemindeki süt ineklerinin beslenmesi I. Bu dönemde görülen metabolik hastalıklar ve besleme ile önlenmesi. Kafkas Univ Vet Fak Derg, 16(1), 159-166.
Beagley JC, Whitman KJ, Baptiste KE, Scherzer JJ, 2010: Physiology and treatment of retained fetal membranes in cattle. J Vet Intern Med, 24, 261- 268.
Chung YH, Pickett MM, Cassidy TW, Varga GA, 2008: Effects of prepartum dietary carbohydrate source and monensin on periparturient metabolism and lactation in multiparous cows. J Dairy Sci, 91, 2744- 2758.
Duffield T, 2014: Subklinik Ketozis’in sağlık, süt verimi, üreme performansı ve sürüden çıkarma riski üzerine etkisi. Tusedad, 4, 18-19.
Furll M, Deniz A, Westphal B, Illing C, Constable PD, 2010: Effect of multiple intravenous injections of butaphosphan and cyanocobalamin on the metabolism of periparturient dairy cows. J Dairy Sci, 93, 4155–4164.
Holt LC, Whittier WD, Gwazdauskas FC, 1989: Early postpartum reproductive profiles in Holstein cows with retainedplacenta and uterine discharges. J Dairy Sci, 72, 533 – 539.
Islam H, Sarder JU, Rahman H, Islam S, Rahman S 2015: Factors affecting the different prophylactic treatments on incidence of retained placenta in Holstein Friesian crossbred cows. Bangladesh livestock journal, 1, 10-12.
Joksimović-Todorović M, Davidović V, 2013:
Immunosuppression – postpartum diseases of dairy cows. Biotechnol Anim Husb, 29(2), 211-222.
Kennedy DG, Cannavan A, Molloy A, O’Harte F, Taylor SM, Kennedy S and Blanchflower WJ, 1990: Methylmalonyl-CoA mutase (EC 5.4.99.2) and methionine synthetase (EC 2.1.1.13) in the tissues of cobalt-vitamin B12 deficient sheep. Br J Nutr, 64, 721–732.
Kim IH, Na KJ, Yang MP, 2005:. Immune responses during the peripartum period in dairy cows with postpartum endometritis. J Reprod Dev, 51, 757- 764.
Könyves L, Szenci O, Jurkovich V, Tegzes L, Tirián A, Solymosi N, Gyulay G, Brydl E, 2009: Risk assessment and consequences of retained placenta for uterine health, reproduction and milk yield in dairy cows. Acta Vet Brno, 78, 163–172.
Kumari S, Prasad S, Patbandha TK, Pathak R, Kumaresan A, Boro P, Manimaran A, Mohanty TK, 2014: Metabolic indicators for retention of fetal membranes in Zebu and crossbred dairy cattle. Anim Prod Sci, doi: 10.1071/AN14941.
Laven RA, Peters AR, 1996: Bovine retained placenta: aetiology, pathogenesis and economic loss. Vet Rec, 139, 465–71.
LeBlanc SJ, 2008: Postpartum uterine disease and dairy herd reproductive performance: A review. Vet J, 176, 102–114.
Majeed AF, Aboud QM, Hassan MS, Muhammad AY, 2009: Retained fetal membranes in FriesianHolstein cows and effect of some treatment methods. Iraqi J Vet Sci, 23, 5-8.
Markusfeld O, 1987: Periparturient traits in seven high dairy herds. Incidence rates, association with parity, and interrelationships among traits. J Dairy Sci, 70, 158-166.
Mollo A, Veronesi MC, Cairoli F, Soldano F, 1997: The use of oxytocin for the reduction of cow placental retention, and subsequent endometritis. Anim Reprod Sci, 48, 47-51.
Mordak R, Stewart PA, 2015: Periparturient stress and immune suppression as a potential cause of retained placenta in highly productive dairy cows: examples of prevention. Acta Vet Scand, 57(84), 1- 8.
Nogalski Z, Wroński M, Lewandowska B, Pogorzelska P, 2012: Changes in the blood indicators and body condition of high yielding Holstein cows with retained placenta and ketosis. Acta Vet Brno, 81, 359–364.
Nuber U, van Dorland HA, Bruckmaier RM, 2016: Effects of butafosfan with or without cyanocobalamin on the metabolism of early lactating cows with subclinical ketosis. J Anim Physiol Anim Nutr, 100(1), 146–155.
Özyurtlu N, Zonturlu AK, İçen H, Gürgöze SY, Güngör Ö, 2008: Retensiyo sekundinarumlu ineklerde bazı biyokimyasal parametreler ve mineral madde düzeylerinin araştırılması Dicle Üniv Vet Fak Derg, 1(2), 38-41.
Pereira RA, Fensterseifer S, Barcelos VB, Martins CF, Schneider A, Schmitt E, Pfeifer LFM, Del Pino FAB, Corrêa MN, 2013a: Metabolic parameters and dry matter intake of ewes treated with butaphosphan and cyanocobalamin in the early postpartum period. Small Rumin Res, 114, 140– 145.
Pereira RA, Silveira PAS, Montagner P, Schneider A, Schmitt E, Rabassa VR, Pfeifer LFM, Del Pino FAB, Pulga ME, Corrêa MN, 2013b: Effect of butaphosphan and cyanocobalamin on postpartum metabolism and milk production in dairy cows. Animal, 7, 1143–1147.
Rollin E, Berghaus RD, Rapnicki P, Godden SM, Overton MW, 2010: The effect of injectable butaphosphan and cyanocobalamin on postpartum serum betahydroxybutyrate, calcium, and phosphorus concentrations in dairy cattle. J Dairy Sci, 93, 978– 987.
Seifi HA, Dalir B, Farzaneh N, Mohr M, Gorji-Dooz M, 2007: Metabolic changes in cows with or without retained fetal membranes in transition period. J Vet Med, 54, 92-97.
Yeon KH, Kim HI, 2005: Risk factors for retained placenta and the effect of retained placenta on the ocfurence of postpartum disease and subsequent reproductive performance in dairy cows. J Vet Sci, 6(1), 53-59.
Zubair M, Ahmad M, 2014: An insight into the recent advances on the physiology and treatment of retention of fetal membranes in cattle. Adv Anim Vet Sci, 2, 73–77.